Understanding the Current Rating
The 'Buy' rating assigned to Apollo Hospitals Enterprise Ltd. indicates a positive outlook on the stock’s potential for capital appreciation and value creation for investors. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s investment merit in the current market environment.
Quality Assessment
As of 28 July 2026, Apollo Hospitals demonstrates strong operational quality. The company holds a 'good' quality grade, supported by a high Return on Capital Employed (ROCE) of 17.13%, signalling efficient use of capital to generate profits. This level of management efficiency is a critical indicator of sustainable business performance. Furthermore, Apollo has reported positive results for ten consecutive quarters, underscoring consistent profitability and operational stability. The latest half-year Profit After Tax (PAT) stands at ₹1,046.14 crores, reflecting a robust growth rate of 37.31% compared to previous periods.
Valuation Perspective
The stock’s valuation is currently graded as 'fair'. Apollo Hospitals trades at an Enterprise Value to Capital Employed ratio of 8.4, which is considered reasonable relative to its sector peers. This valuation level suggests the stock is priced attractively, especially given its strong fundamentals and growth prospects. The company’s Price/Earnings to Growth (PEG) ratio is 1.8, indicating that the stock’s price reasonably reflects its earnings growth potential. Investors benefit from this balance, as the stock is not excessively expensive despite its large-cap status and healthy growth trajectory.
Financial Trend and Growth
The financial trend for Apollo Hospitals remains positive, with net sales growing at an annualised rate of 19.03% and operating profit expanding by 38.67%. These figures highlight the company’s ability to scale its operations profitably over time. The latest quarterly net sales reached ₹6,605.50 crores, marking a record high. Additionally, the half-year ROCE has improved to 17.41%, reinforcing the company’s efficient capital utilisation. Over the past year, the stock has delivered a total return of 20.32%, while profits have surged by 35.3%, reflecting strong earnings momentum that supports the current rating.
Technical Analysis
From a technical standpoint, Apollo Hospitals is rated as 'bullish'. The stock has shown resilience and upward momentum, with a 6-month return of 29.49% and a year-to-date gain of 25.93%. The recent one-month performance of +3.21% and a slight positive movement of +0.29% on the day of analysis (28 July 2026) further indicate sustained investor interest and confidence. This bullish technical outlook complements the fundamental strengths, making the stock attractive for both long-term investors and traders.
Institutional Confidence
Institutional investors hold a significant 65.44% stake in Apollo Hospitals, reflecting strong confidence from knowledgeable market participants. These investors typically conduct thorough fundamental analysis before committing capital, which adds credibility to the stock’s investment case. High institutional ownership often contributes to stock price stability and can be a positive signal for retail investors considering entry.
Summary of Current Position
In summary, Apollo Hospitals Enterprise Ltd. is rated 'Buy' due to its solid quality metrics, fair valuation, positive financial trends, and bullish technical indicators. The company’s consistent growth in sales and profits, efficient capital management, and strong institutional backing provide a compelling case for investors seeking exposure to the hospital sector. While the rating was last updated on 11 May 2026, the current data as of 28 July 2026 confirms the stock’s favourable outlook and potential for continued value appreciation.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Investor Considerations
Investors should note that while Apollo Hospitals is favourably positioned, the hospital sector can be influenced by regulatory changes, healthcare policy shifts, and macroeconomic factors affecting discretionary healthcare spending. The company’s strong fundamentals and valuation cushion provide some protection against volatility, but ongoing monitoring of quarterly results and sector developments remains prudent.
Comparative Market Context
Compared to broader market indices and sector peers, Apollo Hospitals has outperformed over the past year, delivering a 20.32% return versus more modest gains in the healthcare sector overall. This relative strength is underpinned by the company’s operational excellence and growth initiatives. The stock’s large-cap status also offers investors a degree of stability compared to smaller, more volatile healthcare stocks.
Conclusion
With a Mojo Score of 75.0 and a 'Buy' grade, Apollo Hospitals Enterprise Ltd. presents a compelling investment opportunity as of 28 July 2026. The combination of quality, fair valuation, positive financial trends, and bullish technical signals supports this recommendation. Investors seeking exposure to a leading hospital chain with consistent growth and strong institutional support may find this stock well-suited to their portfolios.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
